MedPath

Traditional Chinese medicine as a new treatment for surgical site infection in patients with cesarean delivery: a randomized controlled trial

Phase 4
Completed
Conditions
surgical site infection in patients with cesarean delivery
Registration Number
ITMCTR2100005436
Lead Sponsor
ingbo Women and Children's Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria

(1) single and term pregnancies, (2) failed vaginal labor (OS 10 cm), and (4) CD performed due to fetal head descent.

Exclusion Criteria

The exclusion criteria were as follows: (1) gestational diabetes mellitus (GDM) or (2) hypertension or other complications. All participants provided written informed consent.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.